Literature DB >> 14597553

The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates.

Nicole Schoenfeld1, Manuel K A Bauer, Stefan Grimm.   

Abstract

Here we describe the isolation of C33/CD82/KAI1 in a screen for apoptosis-inducing genes. C33 is a gene that is downregulated in many metastatic tumor cells and the expression of which can attenuate the process of metastases formation in a variety of tumors. In accordance, we observed cell death induction by C33 in many different cell types. C33 seems to promote cell death by the generation of reactive oxygen intermediates (ROIs). These ROIs, however, are not derived from the mitochondrial respiratory chain as in most other scenarios leading to apoptosis. We observed that C33 renders cells sensitive to ROIs by causing the specific release of the intracellular antioxidant glutathione (GSH) from cells. Moreover, C33 activates the GTPase Cdc42, which mediates GSH release and apoptosis induction and allows to detect the formation of ROIs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597553     DOI: 10.1096/fj.03-0420fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction.

Authors:  Ryota Iwasawa; Anne-Laure Mahul-Mellier; Christoph Datler; Evangelos Pazarentzos; Stefan Grimm
Journal:  EMBO J       Date:  2010-12-24       Impact factor: 11.598

2.  KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.

Authors:  Wen Liu; Megumi Iiizumi-Gairani; Hiroshi Okuda; Aya Kobayashi; Misako Watabe; Sudha K Pai; Puspa R Pandey; Fei Xing; Koji Fukuda; Vishnu Modur; Shigeru Hirota; Kazuyuki Suzuki; Toshimi Chiba; Masaki Endo; Tamotsu Sugai; Kounosuke Watabe
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

3.  Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction.

Authors:  A Lemarie; L Huc; E Pazarentzos; A-L Mahul-Mellier; S Grimm
Journal:  Cell Death Differ       Date:  2010-08-13       Impact factor: 15.828

Review 4.  Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  FEBS Lett       Date:  2011-08-27       Impact factor: 4.124

5.  Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma.

Authors:  Huachuan Zheng; Koichi Tsuneyama; Chunmei Cheng; Hiroyuki Takahashi; Zhengguo Cui; Kazuhiro Nomoto; Yoshihiro Murai; Yasuo Takano
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

6.  The pathobiological features of gastrointestinal cancers (Review).

Authors:  Xue Yang; Yasuo Takano; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2012-03-01       Impact factor: 2.967

7.  The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  Genes Cancer       Date:  2010-07-01

8.  Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.

Authors:  Rafijul Bari; Yanhui H Zhang; Feng Zhang; Nick X Wang; Christopher S Stipp; Jie J Zheng; Xin A Zhang
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

9.  Mitochondrial Ca(2+) influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction.

Authors:  M-S Hwang; C T Schwall; E Pazarentzos; C Datler; N N Alder; S Grimm
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

10.  Determining signalling nodes for apoptosis by a genetic high-throughput screen.

Authors:  Bevan Lin; Derek Huntley; Ghada Abuali; Sarah R Langley; George Sindelar; Enrico Petretto; Sarah Butcher; Stefan Grimm
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.